Clinical Trial Update: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency [NA]

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial evaluates cholecalciferol (vitamin D3) for improving survival in patients with newly diagnosed cancer and vitamin D insuf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Non-hodgkin Lymphoma
• Anaplastic Large Cell Lymphoma
• Angioimmunoblastic T-cell Lymphoma
• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Enteropathy-associated T-cell Lymphoma
• Hepatosplenic T-cell Lymphoma
• Mature T-cell and Nk-cell Non-hodgkin Lymphoma

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Mayo Clinic | Conditions: Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma | NA | Status: ACTIVE_NOT_RECRUITING